title: [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells].
abstract: OBJECTIVE
  To investigate the inhibiting effect of classII major histocompatibility complex transactivator (CIITA) anti-sense cDNA on MHCII molecules expression.
  
  
  METHODS
  CIITA antisense cDNAs (arII1, arII2 and arII3) were obtained from Raji cell by RT-PCR, and then inserted into the pcDNA3.1B plasmid. The stable transfectants of Hela cell were tested for CIITA protein by immunohistochemistry, and classic MHCII molecules (HLA-DR, -DP, -DQ) induction through recombinant human IFN-gamma by flow cytometry. mRNAs of CIITA, invariant chain and classic MHCII molecules were detected by RT-PCR.
  
  
  RESULTS
  The effect of arII2 was the best. When induced with IFN-gamma, the expression of CIITA protein was inhibited by 87.23%, and that of HLA-DR, -DP and -DQ was almost totally inhibited on arII2 positive Hela cells. The mRNA contents of CIITA, HLA-DR, -DP, -DQ and invariant chain were decreased significantly (P < 0.05).
  
  
  CONCLUSIONS
  arII2 inhibits CIITA and thus the family of MHCIImolecules regulated by CIITA, therefore, it provides a novel approach to graft versus host disease study in hematopoietic stem cell transplantation.
authors.affiliation: Institute of Hematology, the Affiliated Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
authors.forename: Rong
authors.initials: R
authors.lastname: Guo
authors.forename: Ping
authors.initials: P
authors.lastname: Zou
authors.forename: Hua-hua
authors.initials: HH
authors.lastname: Fan
authors.forename: Lei
authors.initials: L
authors.lastname: Cui
authors.forename: Yi-lin
authors.initials: YL
authors.lastname: Cao
authors.forename: Bin
authors.initials: B
authors.lastname: Zheng
authors.forename: Li
authors.initials: L
authors.lastname: Gao
authors.forename: Feng
authors.initials: F
authors.lastname: Gao
authors.forename: Hua-zhong
authors.initials: HZ
authors.lastname: Lu
mesh_terms: D016373:DNA, Antisense / Q000235:genetics / Q000378:metabolism*; D018076:DNA, Complementary / Q000235:genetics; D005434:Flow Cytometry; D005786:Gene Expression Regulation / Q000187:drug effects; D006367:HeLa Cells; D000949:Histocompatibility Antigens Class II / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000494:pharmacology; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000235:genetics* / Q000378:metabolism; D014162:Transfection
chemical_list: D016373:DNA, Antisense; D018076:DNA, Complementary; D000949:Histocompatibility Antigens Class II; C083728:MHC class II transactivator protein; D009687:Nuclear Proteins; D012333:RNA, Messenger; D015534:Trans-Activators; D007371:Interferon-gamma